Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.69+0.01 (+2.10%)
Close on Nov 18, 2026Market cap $8.09MP/E –Yield –
Radiopharm Theranostics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Radiopharm Theranostics's price to sales ratio was 3.0× on Nov 11, 2026, against 8.7× a year earlier. Over the last 2 years it ranged from 3.0× to 23.6×, with a median of 10.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.0× | −6.9 |
| 2025 | Dec 31, 2025 | 10.0× | −9.4 |
| 2024 | Dec 31, 2024 | 19.3× | – |
See a number that looks wrong?